S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69
S&P 500   4,397.94
DOW   34,265.37
QQQ   351.69

Best Stocks Under $10.00 for 2022

A common mistake among novice investors is confusing an undervalued stock with a cheap stock. When a stock trades under $5 (often called penny stocks), it can be easy for an investor to understand why the stock carries such a low price. But when a stock trades below $10, a little more research is required. This is particularly true when the broader market is in a sell-off. Before attempting to buy stocks under 10 dollars, there are some important things to know.

SHOULD I BUY STOCKS UNDER $10?

The simple answer is “Of course you should.” A common fallacy among even the most experienced investors is failing to understand the difference between a stock that is cheap and one that is undervalued. It’s an interesting aspect of human psychology. A stock that is trading at $200 could decline by 25% and investors will swoop in to buy it “on sale”. But if a $12 stock drops 20% it becomes untouchable.

The problem with this approach is it assumes “high price good, low price bad.” And in fairness, that can be true. And you should not read another word of this article without internalizing this simple truth. Many stocks that trade under $10 do so because they present obvious and fundamentally problematic issues that are suppressing their growth.

So the first thing I would say to investors looking to buy stocks under $10 is be sure you’re ready, and able, to do some research. Simply throwing your hard-earned money at a stock because you’ve heard the mantra “buy low, sell high” is foolish.

But the same can be said of investing in any stock. And if you’re reading this article, I hope you already understand that stocks over time can be an excellent and sound investment. Stock prices, no matter the price, can fluctuate wildly. But over time, investing in stocks has proven to be the most reliable path to reaching your financial goals.

And the simple truth is that a stock that is trading under $10 can offer you the ability to make huge gains. But that is, if you know what to look for. Fortunately, in this article, we’ve done a lot of that research for you.

But there is one caveat about investing in stocks under $10. This should only make up a small portion of the stock portion of your portfolio. The majority of your investment in equities (another name for stocks) should focus on solid, stable companies. And depending on your investment style, you should look for companies that pay a dividend.

You should also not invest in stocks under $10 to replace money you have set aside in bonds or cash. This should be money that you are already investing in the market.

HOW IS A COMPANY’S SHARE PRICE CALCULATED?

If you’re a more experienced investor this is just a basic review. But if you’re a relatively new investor this may help answer a lot of questions.

To understand why buying stocks under $10 can come with an elevated risk you need to understand how a company’s stock price is calculated. There are two data points to look for.

The first is a company’s market capitalization (or market cap). That is a rough estimation of how much a company is worth. The second number is the number of outstanding shares (also called shares outstanding – the meaning is the same). This is, as the name suggests, the number of common shares available to be bought.

To calculate a company’s stock price, you divide the company’s current market capitalization by its number of outstanding shares.

Here’s an example that keeps the math easy. A stock that is valued at $100 million and has 1 million outstanding shares has a share price of $100. But a stock that is valued at $100 million and has 100 million outstanding shares has a share price of $10.

The important thing to take away from that example is a stock’s price does not necessarily reflect the market value of the company.

Now here’s a real world example. On March 27, General Electric (NYSE:GE) had a market cap of $66.37 billion. The company had 8.74 billion outstanding shares. When you divide the market cap by the outstanding shares you get 7.59.

66.37/8.74 = 7.59

This means at that moment, one share of GE stock was valued at $7.59.

WHY DO COMPANIES ISSUE SHARES?

Remember earlier when looked at the example of two companies that were both valued at $100 million. Why would one company have 100 million shares available and the other only 1 million?

First of all, if you’re asking that question good for you. You’re on your way to being a sound investor. But understanding the answer is equally important. So let’s go back to the basics so you understand why companies issue shares.

Companies issue shares as a way to raise money that they don’t have to pay back. This is because, unlike a loan where a company borrows money from a financial institution or hedge fund, shares are bought and sold by other investors. That’s why it’s an investment, right? An investor is giving the company money (in the form of share purchases) in return for the chance that the share price will go higher. This means the value of the company will rise.

So in the earlier example, the company that only has 1 million shares outstanding has a higher demand for its stock. Therefore, if all things are equal (i.e. the market cap of the two companies are the same), that company’s stock will be more valuable.

WHAT ARE THE REWARDS OF STOCKS UNDER $10?

The reward of buying stocks under $10 is the opportunity for growth. If you can buy 1000 shares of a stock that is trading at $8, you would only need the stock to increase in value by $8 to double your investment. If you were

That, however, is easier said than done. And many investors have seen that $8,000 investment evaporate as they bought shares of a falling knife. Still, if investors can find the right stock, stocks under $10 are one of the best ways to capture a significant gain without a large investment.

That brings up a second point. Stocks under $10 are more accessible for investors without a lot of money to put into the market. Robinhood and other trading apps are designed on this principle. If you only have a small amount of money to invest, you don’t have to put all your eggs in one basket. In practical terms, and investor with $10,000 to invest could only buy about five shares of Amazon (NASDAQ:AMZN). But they could buy over 150 shares of Lovesac (NASDAQ:LOVE), a furniture retailer that is currently trading below $7 a share.

This also makes stocks under $10 a great option for diversification. Not only can you look at different sectors, but you can also dabble in international stocks.

WHAT ARE THE RISKS OF STOCKS UNDER $10?

One of the risks of buying a stock that is priced under $10 is the risk of share dilution. Generally, the number of outstanding shares is driven by simple supply and demand. A company that issues a solid earnings report, or comes out with a new product, etc. will see their outstanding shares decline because there will be more buyers than sellers. In other words, the stock is harder to buy. If an investor wants to buy it, a seller will demand a higher price to let their shares go. And when there are more sellers than buyers, there will be a higher number of outstanding shares. In other words, sellers have to accept a lower price for the shares they purchased to entice a buyer to buy.

However, when a company gets into financial trouble, it becomes difficult for them to get loans. Think of your personal finances. If you are looking to finance a car or a house, banks want to make sure you have enough available cash on a monthly basis so you can make the payment.

It’s no different for a company. When a company has limited free cash flow (FCF), they are seen as a credit risk. This simply means lenders believe there is a high probability that the company will default on the loan.

When this happens, one strategy they may execute is to issue more shares. This almost always dilutes the value of the existing shares, which in turn drives the price down further.

Issuing new shares is different from a stock split. A company that offers a stock split is simply trying to make its stock less expensive for retail (individual) investors. But when a company issues a split, they are giving current shareholders more shares at a lower price (e.g. an investor that owned 100 shares at $40 now owns 200 shares at $20).

Another risk with buying stocks under $10 includes the risk of increased competition. Young startup companies often have a first mover advantage. Because they are creating a new market, they have no competition and have no price pressure. However, as more competitors enter the market, a company may face pressure both on the price they charge and their profit margin. If the company is slow to adapt to the competition, their stock price may sink to extremely low levels.

Yet another risk to buying stocks under $10 is that they may be in a cyclical industry. A retailer may see their stock spike during the holiday season as investors anticipate greater revenue and profit. However, for the remainder of the year, the company may not be able to sustain that revenue. That’s another reason the stock may sink.

A final risk to consider is the stock is what it is, a low- to no-growth stock. If you look at the price history of a stock, it may just trade in a specific range. In that case, a stock under $10 may still be a worthwhile investment if it pays a nice dividend.

WHAT ARE THE BEST STOCKS UNDER $10?

If you’ve followed this article and understand both the pros and cons of stocks under $10, let’s take a look at how you can put that information to work in the middle of one of the greatest stock sell-off’s in history.

On the one hand, there are a number of quality companies that have seen their share price reach uncomfortably low levels. But some of these stocks are in industries like hospitality that have been particularly affected by the coronavirus. And while these stocks are generally perceived to see increased, pent-up demand once the coronavirus threat recedes, it may be some time before this increased demand shows up in the stock price.

Stocks Under 10 Dollars

Value investing opportunities do exist—if you're looking in the right places. Putting together a list of the best stocks under $10.00 requires investors to do their homework. At a price of under $10, these companies are not penny stocks. In fact many companies have a large market cap. But just because a stock is trading for a low price doesn’t make it a great value.

One of the biggest assets an investor can have is time. If you’ve done your due diligence and believe in the overall financial health and direction of the company, buying stocks under $10 can be very profitable. If you have the time and patience to hold the stock through many economic cycles, here are some stocks to consider.


Calibre Mining logo

#1 - Calibre Mining

OTCMKTS:CXBMF
Stock Price: $1.04 (-$0.04)
Average Trading Volume: 211,120 shares
Consensus Rating: Buy (3 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.33 (124.4% Upside)
Calibre Mining Corp. is a gold mining and exploration company, which engages in the acquisition, exploration, and development of natural resource properties in Nicaragua. It is involved in the operation of Limon, Libertad gold mines, and Pavon Gold Project. The company was founded by Blayne B. Johnson on January 15, 1969 and is headquartered in Vancouver, Canada.
ADMA Biologics logo

#2 - ADMA Biologics

NASDAQ:ADMA
Stock Price: $1.45 (+$0.02)
PE Ratio: -2.27
Market Cap: $283.93 million
Average Trading Volume: 1.46 million shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $5.70 (293.1% Upside)
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in the manufacturing, marketing and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment comprises of the immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Ramsey, NJ.
CymaBay Therapeutics logo

#3 - CymaBay Therapeutics

NASDAQ:CBAY
Stock Price: $2.89 (+$0.10)
PE Ratio: -2.51
Market Cap: $199.54 million
Average Trading Volume: 540,710 shares
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $10.43 (260.9% Upside)
CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical need. Its products pipeline include Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.
Village Farms International logo

#4 - Village Farms International

NASDAQ:VFF
Stock Price: $5.22 (-$0.38)
PE Ratio: -130.47
Market Cap: $459.97 million
Average Trading Volume: 1.07 million shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $20.13 (285.5% Upside)
Village Farms International, Inc. engages in the management and operation of agricultural greenhouse facilities in United States and Canada. It operates through the following segments: Produce Business; Energy Business; and Cannabis. The Produce Business segment focuses in the production, marketing, and selling of product group which consists of tomatoes, bell peppers, and cucumber. The Energy Business segment offers power that it sells per a long-term contract to its one customer. The Cannabis segment covers the production and supply of cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally through Pure Sunfarms. The company was founded by Michael A. DeGiglio and Albert W. Vanzeyst in 1987 and is headquartered in Delta, Canada.
CES Energy Solutions logo

#5 - CES Energy Solutions

OTCMKTS:CESDF
Stock Price: $1.82 (-$0.05)
Average Trading Volume: 50,040 shares
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $3.11 (70.7% Upside)
CES Energy Solutions Corp., together with its subsidiaries, provides consumable chemical solutions throughout the life-cycle of the oilfield. It provides solutions at the drill-bit, at the point of completion and stimulation, at the wellhead and pump-jack, and through to the pipeline and midstream market. The company's solutions include corrosion inhibitors, demulsifiers, H2S scavengers, paraffin control products, surfactants, scale inhibitors, biocides, and other specialty products. It also designs and implements drilling fluid systems and completion solutions for oil and gas producers; and designs and manufactures production and specialty chemicals for use in the oil and natural gas production markets, the stimulation and fracturing markets, and the pipeline and midstream markets. In addition, the company provides environmental consulting, water management services, and drilling fluids waste disposal services primarily to oil and gas producers; and operates trucks and trailers to transport products in the oil and gas industry. It serves oil and natural gas industry, including multinational producers, intermediate oil and natural gas operators, independent juniors, and joint ventures, as well as pipeline and mid-stream markets in western Canada and the United States. The company was formerly known as Canadian Energy Services & Technology Corp. and changed its name to CES Energy Solutions Corp. in June 2017. CES Energy Solutions Corp. was incorporated in 1986 and is headquartered in Calgary, Canada.
Secure Energy Services logo

#6 - Secure Energy Services

OTCMKTS:SECYF
Stock Price: $4.63 (-$0.17)
Average Trading Volume: 12,716 shares
Consensus Rating: Buy (9 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $7.34 (58.6% Upside)
Secure Energy Services, Inc. engages in the provision of safe and environmentally responsible fluids and solids solutions to the oil and gas industry. It operates through the following segments: Midstream Infrastructure, Environmental and Fluid Management, and Corporate. The Midstream Infrastructure segment operates facilities throughout western Canada, in North Dakota and in Oklahoma and helps upstream oil and natural gas companies with the processing, storing, shipping and marketing of crude oil; processing of waste; and water treatment and disposal. The Environmental and Fluid Management segment focuses on landfill disposal facilities; onsite abandonment, remediation and reclamation management; and drilling, completion and production fluid operations management for oil and gas producers in western Canada. The company was founded in 2007 and is headquartered in Calgary, Canada.
UserTesting logo

#7 - UserTesting

NYSE:USER
Stock Price: $6.51 (-$0.30)
Market Cap: $916.95 million
Average Trading Volume: 132,524 shares
Consensus Rating: Buy (10 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $13.56 (108.2% Upside)
UserTesting, Inc. engages in the operation of a software-as-a-service (SaaS) platform that enables organizations to know experiences of people as they engage with products, designs, apps, processes, concepts, or brands in the United States, the United Kingdom, and internationally. Its platform captures customer perspectives from targeted audiences who share their thoughts for digital, real-world, or omnichannel experiences. The company sells through a direct selling motion with field sales representatives; and inside sales organization that sells to mid-market, and small and medium-sized business customers. It serves customers in B2B and B2C technology, health and fitness, retail and apparel, travel and hospitality, financial services, automotive and transportation, food and beverage, consumer products, and other industries. The company was incorporated in 2007 and is based in San Francisco, California.
Energy Transfer logo

#8 - Energy Transfer

NYSE:ET
Stock Price: $9.17 (-$0.36)
PE Ratio: 5.09
Market Cap: $29.17 billion
Average Trading Volume: 19.78 million shares
P/E Ratio: 5.1
Dividend Yield: 6.40%
Consensus Rating: Buy (13 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $13.31 (45.1% Upside)
Energy Transfer LP provides natural gas pipeline transportation and transmission services. It operates through the following segments: Intrastate Transportation and Storage, Interstate Transportation and Storage, Midstream, NGL and Refined Products Transportation and Services, Crude Oil Transportation and Services, Investment in Sunoco LP, Investment in USAC, and All Other. The Intrastate Transportation and Storage segment owns and operates natural gas transportation pipelines. The Interstate Transportation and Storage segment includes transportation pipelines, storage facilities and gathering systems and deliver the natural gas to industrial end-users and other pipelines. The Midstream segment consists of natural gas gathering, compression, treating, processing, storage, and transportation. The NGL and Refined Products Transportation segment engages in the operations transport, store and execute acquisition and marketing activities utilizing a complementary network of pipelines, storage and blending facilities, and strategic off-take locations that provide access to multiple NGL markets. The Crude Oil Transportation and Services segment provides transportation, terminalling, acqui
Nuvation Bio logo

#9 - Nuvation Bio

NYSE:NUVB
Stock Price: $9.68
Market Cap: $2.11 billion
Average Trading Volume: 725,755 shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $17.40 (79.8% Upside)
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting CDK2, CDK4, and CDK6. It is also developing NUV-868, a selective inhibitor of the BET family of epigenetic transcriptional regulators; NUV-569, a differentiated selective inhibitor of the Wee1 kinase; NUV-1182, an adenosine receptor inhibitor; and DDC platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to androgen receptor-expressing cancer cells , as well as PARP inhibitor to ER-expressing cancer cells. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was incorporated in 2018 and is headquartered in New York, New York.
Custom Truck One Source logo

#10 - Custom Truck One Source

NYSE:CTOS
Stock Price: $7.37 (-$0.17)
PE Ratio: -5.54
Market Cap: $1.82 billion
Average Trading Volume: 276,574 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $10.67 (44.7% Upside)
Custom Truck One Source, Inc. engages in the sale and rental of truck and heavy equipment. The firm offers aftermarket parts and service, equipment customization, remanufacturing, financing solutions, and asset disposal services. The company is headquartered in Kansas City, MO.
Hudbay Minerals logo

#11 - Hudbay Minerals

NYSE:HBM
Stock Price: $7.66 (-$0.36)
PE Ratio: -8.91
Market Cap: $2.00 billion
Average Trading Volume: 1.09 million shares
Dividend Yield: 0.25%
Consensus Rating: Buy (11 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $13.40 (74.9% Upside)
HudBay Minerals, Inc. operates as a mining company. The firm engages in the production of copper concentrate, molybdenum concentrate and zinc metal. It focuses on the discovery, production and marketing of base and precious metals. The company was founded on January 16, 1996 and is headquartered in Toronto, Canada.
Lineage Cell Therapeutics logo

#12 - Lineage Cell Therapeutics

NYSEAMERICAN:LCTX
Stock Price: $1.57 (-$0.08)
PE Ratio: -19.63
Market Cap: $264.64 million
Average Trading Volume: 1.09 million shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $6.00 (282.2% Upside)
Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Ca
ESS Tech logo

#13 - ESS Tech

NYSE:GWH
Stock Price: $6.62 (-$0.29)
Market Cap: $1.00 billion
Average Trading Volume: 511,521 shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $25.50 (285.2% Upside)
ACON S2 Acquisition Corp. entered into a definitive business combination agreement with ESS Tech, Inc.
Kinross Gold logo

#14 - Kinross Gold

NYSE:KGC
Stock Price: $5.65 (-$0.16)
PE Ratio: 7.15
Market Cap: $7.03 billion
Average Trading Volume: 16.70 million shares
P/E Ratio: 7.2
Dividend Yield: 2.07%
Consensus Rating: Buy (9 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $9.98 (76.5% Upside)
Kinross Gold Corp. operates as an exploration company. It engages in the production, acquisition, exploration and development of gold bearing properties in Canada, United States, the Russian Federation, Brazil, Ecuador, Chile, Ghana and Mauritania. The products are gold and silver produced in the form of dore. The company operates through the following business segments: Fort Knox, Round Mountain, Kettle River-Buckhorn, Kupol, Paracatu, Crixas, La Coipa, Maricunga, Tasiast and Chirano. The company was founded by Robert MacKay Buchan on May 31, 1993 and is headquartered in Toronto, Canada.
CEMEX logo

#15 - CEMEX

NYSE:CX
Stock Price: $5.85 (-$0.44)
PE Ratio: 14.27
Market Cap: $8.60 billion
Average Trading Volume: 7.42 million shares
P/E Ratio: 14.3
Consensus Rating: Buy (8 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $9.96 (70.2% Upside)
CEMEX SAB de CV engages in the production, distribution, marketing, and sale of cement, ready-mix concrete, and aggregates. It operates though the following geographical segments: Mexico; United States; Europe; South, Central America and the Caribbean (SCA&C); Asia, Middle East and Africa (AMEA); and Others. The Europe segment covers United Kingdom, Germany, France, Spain, and Czech Republic, Poland and Latvia, as well as trading activities in Scandinavia, and Finland. The SCA&C segment includes Colombia, Panama, Costa Rica, Caribbean TCL, the Dominican Republic, Puerto Rico, Nicaragua, Jamaica, the Caribbean, El Salvador, and Guatemala. The EMEA segment comprises of Egypt, Israel, the Philippines, and the United Arab Emirates. The Others segment refers to the cement trade maritime operations, information technology solutions business, and other corporate entities as well as other minor subsidiaries with different lines of business. The company was founded by Lorenzo Zambrano Gutierrez in 1906 and is headquartered in San Pedro Garza Garcia, Mexico.
ironSource logo

#16 - ironSource

NYSE:IS
Stock Price: $6.13 (-$0.59)
Market Cap: $6.21 billion
Average Trading Volume: 3.91 million shares
Consensus Rating: Buy (14 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $13.02 (112.4% Upside)
ironSource Ltd. operates a business platform for app developers and telecom operators. Its platforms include Sonic solution suite that supports developers to launch, monetize, and scale their apps and games by providing solutions for app discovery, user growth, content monetization, analytics, and publishing; and Aura solution suite, which allows telecom operators to enrich the device experience by creating new engagement touchpoints that deliver relevant content for their users across the entire lifecycle of the device. The company was founded in 2010 and is based in Tel Aviv, Israel.
PureCycle Technologies logo

#17 - PureCycle Technologies

NYSE:PCT
Stock Price: $6.15 (-$0.74)
Market Cap: $721.75 million
Average Trading Volume: 814,057 shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $30.83 (401.4% Upside)
PureCycle Technologies LLC produces recycled polypropylene. It uses a recycling process that separates color, odor, and contaminants from plastic waste feedstock into recycled polypropylene. Its recycling service converts waste plastic into virgin-like plastic. The company was founded in 2015 and is based in Orlando, Florida.
Valens Semiconductor logo

#18 - Valens Semiconductor

NYSE:VLN
Stock Price: $6.12 (-$0.31)
Market Cap: $600.31 million
Average Trading Volume: 37,680 shares
Consensus Rating: Buy (6 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $13.67 (123.3% Upside)
Valens Semiconductor Ltd. is a provider of connectivity solutions for the audio-video and automotive markets. Valens Semiconductor Ltd., formerly known as PTK Acquisition Corp., is based in HOD HASHARON, Israel.
Ginkgo Bioworks logo

#19 - Ginkgo Bioworks

NYSE:DNA
Stock Price: $5.28 (+$0.18)
Market Cap: $7.85 billion
Average Trading Volume: 12.28 million shares
Consensus Rating: Buy (5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $14.67 (177.8% Upside)
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
Zhihu logo

#20 - Zhihu

NYSE:ZH
Stock Price: $4.21 (-$0.23)
Market Cap: $2.36 billion
Average Trading Volume: 2.06 million shares
Consensus Rating: Buy (7 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $13.67 (224.6% Upside)
Zhihu Inc. operates an online content community platform in the People's Republic of China. The company's community allows people to seek inspiration, find solutions, make decisions, and have fun. It also offers technology, business support, and consulting services; information and marketing services; and Internet services. The company was founded in 2011 and is based in Beijing, China.

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.